Rather, KIT is routinely assessed by IHC as a diagnostic marker to distinguish between different cancer types, such as MCT (KIT IHC positive) versus lymphoma (KIT IHC negative), or GIST (KIT IHC positive) versus fibrosarcoma (KIT IHC negative). This evidence concerns the gene KIT and gastrointestinal stromal tumor.